Wednesday, October 27, 2010

Glaxo Agrees to $750 Million Fine for Sale of Bad Products

Regulators say that GlaxoSmithKline, the British drug giant, knowingly sold tainted baby ointment and an ineffective antidepressant.

View the Original article
Enhanced by Zemanta

No comments:

Post a Comment